SRx Health Solutions (SRXH) EBITDA (2010 - 2025)

SRx Health Solutions has reported EBITDA for 16 years, with the latest figure at -$26.9 million in Q2 2025.

• For the quarter ending Q2 2025, EBITDA fell 565.17% year-over-year to -$26.9 million; the trailing twelve-month figure through Jun 2025 stood at -$20.6 million (down 71.67% YoY), and the FY2025 full-year result was -$3.8 million, down 190.41% from the prior year.
• EBITDA for Q2 2025 stood at -$26.9 million, down from -$1.1 million in the prior quarter.
• The five-year high for EBITDA was $8.5 million in Q4 2024, with the low at -$26.9 million in Q2 2025.
• Historically, EBITDA has averaged -$5.3 million across 5 years, with a median of -$3.6 million in 2022.
• Annual changes were most pronounced in 2024 — EBITDA jumped 323.91% — and 2025, when it tumbled 565.17%.
• SRx Health Solutions' EBITDA stood at -$5.0 million in 2021, then sank by 385.37% to -$24.2 million in 2022, then surged by 47.33% to -$12.7 million in 2023, then surged by 166.89% to $8.5 million in 2024, then tumbled by 416.38% to -$26.9 million in 2025.
• The last three EBITDA figures came in at -$26.9 million (Q2 2025), -$1.1 million (Q1 2025), and $8.5 million (Q4 2024), per Business Quant data.